FibroFind

FibroFind is a pre-clinical research company that uses multi-organ platforms for the development and efficacy-determination of drugs that suppress fibrosis.

[FibroFind @FibroFind]

A fascinating new paper describing the role of mitochondrial DNA in regulating the phenotypic features of cellular senescence which is co-authored by our CSO @derekamann1

[nature @Nature]

Nature research paper: Apoptotic stress causes mtDNA release during senescence and drives the SASP https://t.co/2uAbAggKfb

[FibroFind @FibroFind]

@FibroFind are pleased to be sponsoring the very first First International Conference of Liver Pathobiology: From Bench to Bedside held in Chania, Crete which starts today!

[FibroFind @FibroFind]

@CancerInflam As @derekamann1 showed in his 2021 Journal of Immunology paper, even modest exercise can prevent liver pathologies that underpin development of cancer. See https://t.co/cfANspQeu3.

[FibroFind @FibroFind]

@DrLoomba @derekamann1 Thank you Dr Loomba!

[FibroFind @FibroFind]

We did it! We bought a site for a new laboratory and office building right in the heart of the great city of Newcastle! Here is an artist impression of what all be FibroFind new home from where we will put the North East of England firmly on the global biomedical sector map.

[FibroFind @FibroFind]

Latest research output led by our CEO @JelenaMann describing the identification of microRNA regulated pathways within the fibrotic microenvironment of human idiopathic pulmonary fibrosis https://t.co/CoNqFCx6W3

[FibroFind @FibroFind]

A cool new animation describing how @FibroFind are revolutionising the search for new treatments in chronic kidney disease and paving the way for an era in which novel therapeutics are discovered using human rather than animal experimental systems. Enjoy! https://t.co/GfVIdenJbY

[FibroFind @FibroFind]

What a phenomenal achievement and great for our 4 directors all of whom are investigators at Newcastle University

[Derek A Mann @derekamann1]

Very proud to be Professor of Hepatology @UniofNewcastle and especially when we rank 10th in the world for Gastroenterology and Hepatology!

https://t.co/MobKbK8DQ3

[FibroFind @FibroFind]

Metabolic disturbances caused by hepatitis c virus can persist after successful treatment and can be a risk for development of liver cancer. A review co-authored by Prof Derek A Mann published in Journal of Hepatology. https://t.co/rRf9c8vvZC

[FibroFind @FibroFind]

We are very proud!

[Bionow @Bionow]

The competition was super strong for #BionowAwards Start Up of the Year Award. Congratulations to the winner – @FibroFind | Sponsored by @RSMUK

[FibroFind @FibroFind]

We have only gone and done it, FibroFind are the Bionow Start Up of the Year!!

[FibroFind @FibroFind]

It is a privilege and an honour to be able to support youth development in the city of Newcastle and in particular with @NorthernFC who are making great strides in promoting sporting and physical fitness in girls #InternationalWomensDay

[Derek A Mann @derekamann1]

I am extremely proud as Director of @FibroFind that our company sponsors youth development at a great local sports club. @NorthernFC have a commitment to developing girls sport and physical development as this lovely picture. Congrats to the coaches 👏 #InternationalWomensDay

[Jack Leslie @J__Leslie]

Happy to share a preprint of our work on neutrophils and their role in NASH-HCC immunotherapy. @derekamann1 @owen_sansom @BAIR_Head @CR_UK

[FibroFind @FibroFind]

We are honoured and excited to be shortlisted for @Bionow #startup of the Year!

[Bionow @Bionow]

As we count down to the #BionowAwards dinner, we'd like to celebrate our fabulous nominees! First up is #StartUp of the Year Sponsored by @RSMUK and the shortlist is: @Cryoniss_Ltd, @FibroFind & @PandeiaT.

Full list: https://t.co/5Iw9y1EDsK

Book tickets: https://t.co/cxMQSpsMDm

[FibroFind @FibroFind]

We are excited and grateful to be shortlisted for this prestigious award.

[Graham Bond @Bondgp007]

We at @RSMUK are delighted to be once again sponsoring the @Bionow Start Up of the Year 2021 award. Good luck to the shortlisted nominees
•@Cryoniss_Ltd
•@FibroFind
•@PandeiaT

[FibroFind @FibroFind]

Exciting news. We have been shortlisted in two award categories for the @Bionow annual awards - start up of the year and exporter of the year. Well done to the entire team! https://t.co/875cqd93Hr

[FibroFind @FibroFind]

@TrostLab Try the fruit and veg stall outside the RVI, it’s superb!

[FibroFind @FibroFind]

@CJStewart7 Congratulations Chris

[FibroFind @FibroFind]

@HepionPharma Congratulations!

[FibroFind @FibroFind]

We are delighted to have contributed to an exciting pre-clinical study with @HepionPharma showing that their drug CRV431 has anti-tumour activity in a model of liver cancer. https://t.co/zZK2nvl4xC #drugdiscovery #livercancer